// App-Quantinova.ai

OP0231 (2021) : DIFFERENCES IN REAL-WORLD PATIENT CHARACTERISTICS OF 8921 PSORIASIS PATIENTS WITH AND WITHOUT COMORBID PSORIATIC ARTHRITIS USING THE UK BADBIR DATABASE

Researchers

Presenter

  • W. Tillett

Principal Investigators

  • A. Ogdie

  • P. Gorecki

Medical Centers

  • Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom

  • University of Pennsylvania, Perelman School of Medicine, Department of Dermatology, Philadelphia, United States of America

  • Janssen, Medical Affairs, High Wycombe, United Kingdom

  • Janssen Real World Evidence, HEMAR EMEA, High Wycombe, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Dermatology

  • Musculoskeletal

  • Central Nervous System (CNS)

  • Endocrine/metabolic Diseases (ME)

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Psoriatic arthritis

  • Hypertension

  • Depression

  • Inflammatory Arthritis

  • Psoriasis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Ustekinumab

Outcome

  • N/A

Study Design

  • Observational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Abbvie

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved